Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
14 hedge funds and large institutions have $5.33M invested in Zosano Pharma Corporation in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
27% more funds holding
Funds holding: 11 → 14 (+3)
32% less capital invested
Capital invested by funds: $7.85M → $5.33M (-$2.52M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$954K |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$363K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$278K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$28.7K |
| 5 |
CC
Callan Capital
La Jolla,
California
|
+$19.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$528K |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$120K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$28.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.9K |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$15K |
ZSAN Hedge Fund Activity: Q3 2016 in Review
14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2016, worth a combined $5.33M — down 32% from $7.85M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ZSAN positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $954K. The largest seller was Putnam Investments, exiting entirely with an estimated $528K sold.
- 14 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q3 2016, up from 11 in Q2 2016.
- Funds reported $5.33M of Zosano Pharma Corporation stock for Q3 2016, down 32% quarter-over-quarter.
- 5 funds opened new Zosano Pharma Corporation positions in Q3 2016 and 2 closed out, a net change of +3 holders.
- The largest Zosano Pharma Corporation buyer in Q3 2016 was Armistice Capital, an estimated $954K added.
- The largest Zosano Pharma Corporation seller in Q3 2016 was Putnam Investments, an estimated $528K sold.
Based on aggregated 13F filings for Q3 2016.